Bringing anti-cancer technology to market

New technology involves use of an antibody-based cancer therapy that down-regulates a plethora of pathways associated with resistant disease. The approach could advance treatment for patients with many forms of cancer, including breast, colorectal, lung, skin, and other epithelial-derived cancers. (Mehr in: Cancer News — ScienceDaily)